07:00 , Aug 19, 2013 |  BC Week In Review  |  Clinical News

RD-100i OSNA system regulatory update

The U.K.'s NICE issued final guidance recommending Sysmex's RD-100i OSNA system to detect sentinel lymph node metastases during breast surgery in patients with early invasive breast cancer who have a sentinel lymph node biopsy and...
07:00 , Mar 11, 2013 |  BC Week In Review  |  Clinical News

Metasin test regulatory update

The U.K.'s NICE issued draft guidance recommending against use of TIB's Metasin test to detect sentinel lymph node metastases in patients with early invasive breast cancer who have a sentinel lymph node biopsy and in...
07:00 , Mar 11, 2013 |  BC Week In Review  |  Clinical News

RD-100i OSNA system regulatory update

The U.K.'s NICE issued draft guidance recommending Sysmex's RD-100i OSNA system to detect sentinel lymph node metastases in patients with early invasive breast cancer who have a sentinel lymph node biopsy and in whom axillary...
07:00 , Jun 6, 2011 |  BC Week In Review  |  Clinical News

CYFRA 21-1 EIA assay regulatory update

Fujirebio's Fujirebio Diagnostics Inc. unit received 510(k) clearance from FDA for its CYFRA 21-1 EIA assay to monitor disease progression in lung cancer patients. The biomarker assay kit that detects soluble cytokeratin 19 ( CK19;...